#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3420957	B	Inhibition of Escherichia coli RNase H pre-incubated for 10 mins before HTS-1 RNA/DNA duplex substrate addition by fluorescence assay	Escherichia coli	11		assay format	Scientific Literature
2.	ALA3418034	B	Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in DNA 3' end directed cleavage using HTS-2 RNA/DNA duplex substrate by fluorescence assay	Human immunodeficiency virus 1	21		single protein format	Scientific Literature
3.	ALA3418035	B	Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in RNA 5' end directed cleavage using HTS-3 RNA/DNA duplex substrate by fluorescence assay	Human immunodeficiency virus 1	21		single protein format	Scientific Literature
4.	ALA3418036	B	Inhibition of reconstituted HIV1 RNase H using RNA/DNA duplex substrate by fluorescence assay	Human immunodeficiency virus 1	21		single protein format	Scientific Literature
5.	ALA3418037	B	Inhibition of HIV1 recombinant reverse transcriptase polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry	Human immunodeficiency virus 1	21		single protein format	Scientific Literature
6.	ALA3418038	B	Inhibition of HIV1 reverse transcriptase Y181C mutant associated RNase H domain activity assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay	Human immunodeficiency virus 1	7		single protein format	Scientific Literature
7.	ALA3418039	B	Inhibition of HIV1 reverse transcriptase Y181C mutant associated RNase H domain activity assessed as reduction in reduction in DNA 3' end directed cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay	Human immunodeficiency virus 1	7		single protein format	Scientific Literature
8.	ALA3418040	B	Inhibition of HIV1 reverse transcriptase Y181C mutant polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry	Human immunodeficiency virus 1	7		single protein format	Scientific Literature
9.	ALA3418041	B	Inhibition of HIV1 reverse transcriptase L100I/K103N mutant associated RNase H domain activity assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay	Human immunodeficiency virus 1	7		single protein format	Scientific Literature
10.	ALA3418042	B	Inhibition of HIV1 reverse transcriptase L100I/K103N mutant associated RNase H domain activity assessed as reduction in reduction in DNA 3' end directed cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay	Human immunodeficiency virus 1	7		single protein format	Scientific Literature
11.	ALA3418254	B	Inhibition of HIV1 reverse transcriptase L100I/K103N mutant polymerase activity using [3H]TTP and poly(rA)-oligo(dT)16 substrate incubated for 20 mins by liquid scintillation spectrometry	Human immunodeficiency virus 1	7		single protein format	Scientific Literature
12.	ALA3418255	B	Inhibition of Moloney murine leukemia virus reverse transcriptase associated RNase H pre-incubated for 10 mins before HTS-1 RNA/DNA duplex substrate addition by fluorescence assay	Moloney murine leukemia virus	11		assay format	Scientific Literature
13.	ALA3418256	B	Inhibition of Moloney murine leukemia virus reverse transcriptase polymerase activity using Td100/Pd18 DNA-DNA substrate incubated for 30 mins by fluorescence assay	Moloney murine leukemia virus	11		single protein format	Scientific Literature
14.	ALA3418257	B	Inhibition of HIV integrase pre-incubated for 10 mins before DNA substrate addition	Human immunodeficiency virus	20		single protein format	Scientific Literature
15.	ALA3418258	B	Selectivity index, ratio of IC50 for HIV integrase to IC50 for HIV1 recombinant reverse transcriptase associated catalytically active RNase H-mediated domain internal cleavage activity		20		assay format	Scientific Literature
16.	ALA3418259	F	Antiviral activity against HIV infected in human HeLa P4/R5 cells pre-incubated for 16 hrs before virus infection and measured 48 hrs post virus infection by fluorescence-based beta-galactosidase detection assay	Human immunodeficiency virus	9		organism-based format	Scientific Literature
17.	ALA3418260	T	Toxicity against human HeLa P4/R5 cells	Homo sapiens	9		cell-based format	Scientific Literature
18.	ALA3418261	A	Therapeutic index, ratio of CC50 for human HeLa P4/R5 cells to EC50 for HIV infected in human HeLa P4/R5 cells		9		cell-based format	Scientific Literature
19.	ALA3418276	B	Inhibition of HIV1 recombinant reverse transcriptase associated catalytically active RNase H domain assessed as reduction in internal cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay	Human immunodeficiency virus 1	21		single protein format	Scientific Literature